Department of Pediatric Ophthalmology,
Peking University First Hospital,
Peking University Children Vison Institute,
Department of Pediatric Ophthalmology, Peking University First Hospital, Peking University Children Vison Institute
Xiaoqing Li has not added Biography.
If you are Xiaoqing Li and would like to personalize this page please email our Author Liaison for assistance.
[Development of stereopsis among children].
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology Apr, 2009 | Pubmed ID: 19575964
[The transient PVEP acuity assessment for 2 to 5 years old normal children].
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology May, 2010 | Pubmed ID: 20654216
[Evaluation of grating visual acuity development in normal infants].
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology Nov, 2011 | Pubmed ID: 22336065
[A multicenter comparison study on the quantitative detection of bcr-abl (P210) transcript levels in China].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Feb, 2013 | Pubmed ID: 23611214
Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.
Molecular genetics and genomics : MGG Aug, 2013 | Pubmed ID: 23689641
miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
Journal of cancer research and clinical oncology Mar, 2014 | Pubmed ID: 24384875
[A multicenter study on the validation of conversion factor for the conversion of BCR-ABL (P210) transcript levels to the international scale in chronic myeloid leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Feb, 2014 | Pubmed ID: 24606655
Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Sep, 2015 | Pubmed ID: 25809707
Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Sep, 2015 | Pubmed ID: 25813153
MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.
Molecular medicine reports Oct, 2015 | Pubmed ID: 26252115
[A multicenter study on the revalidation of validated conversion factor for the conversion of BCRABL(P210)transcript levels to the international scale in chronic myeloid leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Oct, 2015 | Pubmed ID: 26477757
GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Apr, 2016 | Pubmed ID: 26503214
Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores.
Scientific reports Feb, 2016 | Pubmed ID: 26865505
miR‑30a‑5p in the tumorigenesis of renal cell carcinoma: A tumor suppressive microRNA.
Molecular medicine reports May, 2016 | Pubmed ID: 27035333
Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation.
Journal of human genetics Aug, 2016 | Pubmed ID: 27193224
Low-level prenatal lead exposure and infant sensory function.
Environmental health : a global access science source Jun, 2016 | Pubmed ID: 27266277
Tiny protein detection using pressure through solid-state nanopores.
Electrophoresis Apr, 2017 | Pubmed ID: 28070896
N-Terminal Acetylation Preserves α-Synuclein from Oligomerization by Blocking Intermolecular Hydrogen Bonds.
ACS chemical neuroscience Oct, 2017 | Pubmed ID: 28741930
Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencing.
Scientific reports Aug, 2017 | Pubmed ID: 28765568
Increased Soluble CD137 Levels and CD4+ T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke.
Clinical and translational science Jul, 2018 | Pubmed ID: 29697202
Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia.
Cellular and molecular neurobiology Apr, 2019 | Pubmed ID: 30778712
Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
Nanoscale Mar, 2019 | Pubmed ID: 30892349
A Critical Role of Formyl Peptide Receptors in Host Defense against .
Journal of immunology (Baltimore, Md. : 1950) May, 2020 | Pubmed ID: 32221037
The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Trials Jun, 2020 | Pubmed ID: 32605578
Deciphering mechanism of the herbal formula WuShen in the treatment of postinfarction heart failure.
Phytomedicine : international journal of phytotherapy and phytopharmacology Jan, 2022 | Pubmed ID: 34929563
New treatment for amblyopia based on rules of synaptic plasticity: a randomized clinical trial.
Science China. Life sciences Mar, 2022 | Pubmed ID: 35015247
[A new isoflavone from Dalbergia odorifera and inhibitory activity of its tyrosinase].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica Sep, 2022 | Pubmed ID: 36164905
Distributed search and fusion for wine label image retrieval.
PeerJ. Computer science , 2022 | Pubmed ID: 36262126
Automated assessment of grating acuity in infants and toddlers using an eye-tracking system.
Journal of vision Nov, 2022 | Pubmed ID: 36331256
Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors.
Frontiers in pharmacology , 2023 | Pubmed ID: 36726585
1Department of Pediatric Ophthalmology, Peking University First Hospital, Peking University Children Vison Institute, Peking University,
2School of Intelligence Science and Technology, Peking University,
3School of Psychological and Cognitive Sciences and Beijing Key Laboratory of Behavior and Mental Health, Peking University
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。